Vcanbio Cell & Gene Engineering Co Ltd Sustainability Reports
The company operates in the precision prevention, precision diagnosis, and cell therapy sectors. Its primary activities include stem cell testing, preparation and storage services, along with the research, development, and sales of diagnostic reagents.
Sector: Professional & technical services
Country: China
Exchange: Shanghai Stock Exchange
LEI: 300300FLWFDJPQYVAZ24
FIGI: BBG001S7MH54
6 reports from 2015 to 2025
- Vcanbio Cell & Gene Engineering Co Ltd 2025 Annual Report
- Vcanbio Cell & Gene Engineering Co Ltd 2024 Annual Report
- Vcanbio Cell & Gene Engineering Co Ltd 2023 Annual Report
- Vcanbio Cell & Gene Engineering Co Ltd 2022 Annual Report
- Vcanbio Cell & Gene Engineering Co Ltd 2017 Social Responsibility Report